Arthur F. Ryan - 04 Aug 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
04 Aug 2022
Net transactions value
-$2,174,484
Form type
4
Filing time
08 Aug 2022, 16:12:30 UTC
Previous filing
03 May 2022
Next filing
08 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -2,500 -11% $0.000000 19,682 04 Aug 2022 Direct
transaction REGN Common Stock Options Exercise $1,743,923 +3,613 +18% $482.68 23,295 04 Aug 2022 Direct
transaction REGN Common Stock Sale $3,034,094 -4,887 -21% $620.85 18,408 04 Aug 2022 Direct F1
transaction REGN Common Stock Options Exercise $1,631,537 +4,361 +24% $374.12 22,769 04 Aug 2022 Direct
transaction REGN Common Stock Sale $2,583,120 -4,156 -18% $621.54 18,613 04 Aug 2022 Direct F2
transaction REGN Common Stock Options Exercise $944,375 +2,479 +13% $380.95 21,092 04 Aug 2022 Direct
transaction REGN Common Stock Sale $877,105 -1,410 -6.7% $622.06 19,682 04 Aug 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -4,361 -100% $0.000000* 0 04 Aug 2022 Common Stock 4,361 $374.12 Direct F4
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,479 -100% $0.000000* 0 04 Aug 2022 Common Stock 2,479 $380.95 Direct F5
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,613 -100% $0.000000* 0 04 Aug 2022 Common Stock 3,613 $482.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 4,887 shares of Company stock on August 4, 2022 at prices ranging from $620.16 to $620.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
F2 Represents volume-weighted average price of sales of 4,156 shares of Company stock on August 4, 2022 at prices ranging from $621.00 to $621.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 1,410 shares of Company stock on August 4, 2022 at prices ranging from $622.00 to $622.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
F4 On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
F5 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.